Suven Pharmaceuticals Limited (SUVENPHAR) - Cash Flow Conversion Efficiency

Latest as of December 2023: 0.013x

Based on the latest financial reports, Suven Pharmaceuticals Limited (SUVENPHAR) has a cash flow conversion efficiency ratio of 0.013x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs255.04 Million ≈ $2.76 Million USD) by net assets (Rs19.81 Billion ≈ $214.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Suven Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Suven Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Suven Pharmaceuticals Limited for a breakdown of total debt and financial obligations.

Suven Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suven Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
KONINKLIJKE VOP.UNSP.ADR F:VPK	N/A
Brown-Forman Corporation NYSE:BF-A	0.102x
Grupo Aeroportuario del Centro Norte SAB de CV NASDAQ:OMAB	0.162x
Georg Fischer AG SW:GF	0.197x
RadNet Inc NASDAQ:RDNT	0.062x
MDU Resources Group Inc NYSE:MDU	0.008x
Clear Secure Inc NYSE:YOU	-0.285x
Charoen Pokphand Foods Public Company Limited F:NVAV	0.058x

Annual Cash Flow Conversion Efficiency for Suven Pharmaceuticals Limited (2019–2025)

The table below shows the annual cash flow conversion efficiency of Suven Pharmaceuticals Limited from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Suven Pharmaceuticals Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs18.41 Billion ≈ $199.06 Million	Rs2.88 Billion ≈ $31.16 Million	0.157x	-10.44%
2024-03-31	Rs20.51 Billion ≈ $221.77 Million	Rs3.58 Billion ≈ $38.77 Million	0.175x	-32.73%
2023-03-31	Rs17.35 Billion ≈ $187.65 Million	Rs4.51 Billion ≈ $48.76 Million	0.260x	+20.26%
2022-03-31	Rs15.27 Billion ≈ $165.16 Million	Rs3.30 Billion ≈ $35.69 Million	0.216x	-33.46%
2021-03-31	Rs11.81 Billion ≈ $127.70 Million	Rs3.83 Billion ≈ $41.47 Million	0.325x	-34.05%
2020-03-31	Rs8.45 Billion ≈ $91.36 Million	Rs4.16 Billion ≈ $44.98 Million	0.492x	+476.64%
2019-03-31	Rs5.90 Billion ≈ $63.84 Million	Rs504.05 Million ≈ $5.45 Million	0.085x	--

About Suven Pharmaceuticals Limited

NSE:SUVENPHAR India Drug Manufacturers - Specialty & Generic

Market Cap

$4.40 Billion

Rs406.97 Billion INR

Market Cap Rank

#3908 Global

#167 in India

Share Price

Rs1063.80

Change (1 day)

+4.50%

52-Week Range

Rs967.90 - Rs1149.00

All Time High

Rs1334.20